

FX Medicine Podcast Central
FX Medicine
FX Medicine is at the forefront of ensuring functional and integrative medicine gains the recognition it deserves and ultimately establishes itself as an integral part of standard medical practice. Our podcasts are designed to promote research and evidence based therapeutic practises, acting as a progressive force for change and improvement in patient health and wellbeing.
Episodes
Mentioned books

Nov 26, 2014 • 0sec
Toxicity and Detoxification with Dr Joseph Pizzorno
In this interview Dr Joseph Pizzorno discusses the exciting advances in our understanding and treatment of toxicity and detoxification. After reviewing over 10,000 research papers and trialling his protocols on thousands of patients, Dr Pizzorno is a leading authority on this critical area of health management.
Dr Pizzorno will be speaking at the next BioCeuticals Research Symposium on April 17 - 19, 2015. He, along with 3 other world leading integrative health experts, will be delivering a 3 day masterclass program on the interrelated drivers of health and disease. For more information, visit the BioCeuticals website and click on the Education tab.

Nov 11, 2014 • 0sec
Functional Pain Management
Chronic pain is typically a difficult condition to address, because it is perceived by the sufferer, often without any corresponding objective measure. In this latest FX Medicine podcast we interview Dr Mark Donohoe, an integrative GP with extensive experience in chronic pain management. By differentiating between the different types of pain and their underlying causes, Dr Donohoe offers numerous treatment options that he has found to be of genuine benefit to his patients.

Oct 29, 2014 • 0sec
Successfully treating chronic skin conditions
Amie Skilton is a naturopath who has been in clinical practice for 13 years. She specialises in several areas of clinical practice including weight management, gut restoration, food sensitivities and hormonal conditions. In this interview Andrew Whitfield-Cook interviews Amie on her special interest, that being chronic skin conditions, which includes acne, eczema and psoriasis. Amie shares her knowledge and experience in addressing the underlying causes of skin diseases and expertly provides a wealth of clinical and practical advise for practitioners wanting to learn more about how to use herbs and nutrients to treat these typically stubborn and persistent health conditions.

Oct 22, 2014 • 0sec
Iodine: So much more than just for thyroid
There is no doubt that iodine deficiency is one of the most profound nutritional concerns in Australia. In fact, iodine deficiency is the biggest non-communicable disorder and also a major cause of mental disorder. In this outstanding interview, Mark Donohoe expertly explains the critical importance of this typically misunderstood mineral. After reviewing it's many roles in the body, well beyond thyroid function, he pays special attention to dosing and key clinical strategies for addressing iodine deficiency.

Oct 10, 2014 • 0sec
Optimising Male Reproductive Health
This interview is essential listening for anyone who is interested in implementing practical measures for improving male reproductive health and sexual function. Following up from his recent national seminar series, Dr Bob Buist discusses the healthy male physiology, the key factors that can interfere and impede on this and the nutritional, herbal and lifestyle approaches that have been shown to be of real benefit.

Oct 3, 2014 • 0sec
The Forgotten Organ
In this interview, Dr Mark Donohoe expertly describes what happens to the adrenal glands when we undergo various types of stress. His comprehensive knowledge of adrenal structure and function brings new insights into this often misunderstood organ. In doing so, Dr Donohoe is able to draw a framework for assessment and treatment that will be helpful to all health care practitioners.

Sep 25, 2014 • 0sec
Non-alcoholic fatty liver disease: New insights into the NAFLD epidemic with Dr Bob Buist
Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease in Australia. There is increasing evidence for considering NAFLD as part of metabolic syndrome including obesity, hyperinsulinaemia, insulin resistance, hypertriglyceridaemia and hypertension. Therapies which focus on targeted anitoxidant and anti-inflammatory actions are therefore a worthwhile consideration. Such therapies have the potential to improve liver function leading to a drop in serum aminotransferase levels and inflammation, along with improvements in liver histology and steatosis. In particular, several natural agents have been studied to demonstrate such improvements. Trials using St Mary's thistle, coffee, vitamin E and zinc in NAFLD have shown improvements in liver enzyme levels and biochemistry.
In this interview with Dr Bob Buist, we review some of these key areas of research and offer practical and effective options for treating this increasingly prevalent condition.

Sep 20, 2014 • 0sec
Integrative cardiology: dyslipidemia and hypertension with Dr Mark Houston
Dr Mark Houston, clinical professor of medicine at Vanderbilt University Medical School, discusses the real causes of hypertension and lipid disorders, exploring treatment and nutritional therapies for measurable improvements. Topics include evolution of lipidology, body composition measurement, blood sugar levels, exercise programs, and nutraceutical supplements.

Sep 1, 2014 • 0sec
Protecting bone and cardiovascular health with vitamin K2
In this podcast we interview Hub Regtop on the protective benefits of the 'missing nutrient'.

Aug 25, 2014 • 0sec
A revolution in the prevention and treatment of cardiovascular disease
We have reached a limit in our ability to reduce the incidence of coronary heart disease (CHD) and cardiovascular disease (CVD) utilising the traditional evaluation, prevention, and treatment strategies for the top 5 cardiovascular risk factors – hypertension, diabetes mellitus, dyslipidemia, obesity and smoking.
Statistics show that approximately 50% of patients continue to have CHD or myocardial infarction (MI) despite “normal” levels of these five risk factors as traditionally defined. A more logical and in depth understanding is required of these top five risk factors.
Mark Houston is clinical professor of medicine at Vanderbilt University Medical School, and Medical Director at Hypertension and Vascular Biology Institute and the Life Extension Institute at Saint Thomas Hospital and Medical Center in Nashville, Tennessee. He specializes in hypertension, lipid disorders, prevention, and treatment of cardiovascular diseases, nutrition, clinical age management and general internal medicine.
In this interview, Dr Houston explores the next frontier in the prevention and treatment of cardiovascular disease.